Concepedia

C. Croot

CC

Statistics

Publications

3

Citations

1K

H-Index

3

Active since

2005

Affiliations

North Mississippi Medical Center(Current)

C. Croot is an author at North Mississippi Medical Center specializing in medicine, oncology, and cancer pharmacology.

Publications per year

2005–2017

3

Publications

3

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

Adrian S. Dobs, Ralph V. Boccia, C. Croot et al. · The Lancet Oncology · 2013 · 383 citations

Medicine, Oncology, Pharmacotherapy +11

Randomized Comparison of Epoetin Alfa (40,000 U Weekly) and Darbepoetin Alfa (200 μg Every 2 Weeks) in Anemic Patients with Cancer Receiving Chemotherapy

Roger J. Waltzman, C. Croot, Glen R. Justice et al. · The Oncologist · 2005 · 77 citations · Full text

Medicine, Hematology, Pharmacology +9

1–3 of 3